These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [The characteristics of a parkinsonian syndrome induced in an experiment by a deficiency of nigrostriatal dopamine and by stimulation of the cholinergic neurons of the caudate nucleus]. Kryzhanovskiĭ GN; Atadzhanov MA; Voronina TA; Nerobkova LN Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(6):3-7. PubMed ID: 8160497 [TBL] [Abstract][Full Text] [Related]
6. [Role of the striatal serotoninergic apparatus in Parkinsonian syndrome]. Kryzanovskiĭ GN; Magaeva SV; Trekova NA; Vetrilé LA; Basharova LA; Atadzhanov MA Biull Eksp Biol Med; 1993 May; 115(5):466-9. PubMed ID: 8043821 [TBL] [Abstract][Full Text] [Related]
7. [Effects of intranasally administered substance P in parkinsonian syndrome]. Kryzhanovskiĭ GN; Kucherianu VG; Godlevskiĭ LS; Mazarati AD Biull Eksp Biol Med; 1992 Jan; 113(1):16-9. PubMed ID: 1382692 [TBL] [Abstract][Full Text] [Related]
9. [Appearance of parkinsonian syndrome after administration of delta sleep-inducing peptide into the rat substantia nigra]. Kryzhanovskiĭ GN; Shandra AA; Godlevskiĭ LS; Mikhaleva II Biull Eksp Biol Med; 1990 Feb; 109(2):119-21. PubMed ID: 2337637 [TBL] [Abstract][Full Text] [Related]
10. [Modelling of the parkinsonian syndrome by the administration of kainic acid into the caudate nucleus]. Kryzhanovskiĭ GN; Makul'kin RF; Shandra AA; Godlevskiĭ LS; Rozhkov VS Biull Eksp Biol Med; 1987 Jun; 103(6):650-3. PubMed ID: 3593943 [TBL] [Abstract][Full Text] [Related]
11. [EEG changes and symptomatic parkinsonism after intracaudate administration of dopamine antibodies]. Kryzhanovskiĭ GN; Atadzhanov MA; Magaeva SV; Basharova LA; Vetrilé LA Biull Eksp Biol Med; 1989 Jan; 107(1):13-6. PubMed ID: 2914165 [TBL] [Abstract][Full Text] [Related]
12. The pharmacology of the parkinsonian syndrome producing neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and structurally related compounds. Markey SP; Schmuff NR Med Res Rev; 1986; 6(4):389-429. PubMed ID: 3534484 [No Abstract] [Full Text] [Related]
13. [Formation of a generator of pathologically enhanced excitation in the caudate nucleus in experimental parkinsonism]. Aliev MN; Igon'kina SI; Kryzhanovskiĭ GN Biull Eksp Biol Med; 1981 Dec; 92(12):657-9. PubMed ID: 7326408 [TBL] [Abstract][Full Text] [Related]
14. MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies. Rollema H; Skolnik M; D'Engelbronner J; Igarashi K; Usuki E; Castagnoli N J Pharmacol Exp Ther; 1994 Jan; 268(1):380-7. PubMed ID: 8301579 [TBL] [Abstract][Full Text] [Related]
15. Modification by apomorphine of the circling behaviour in the rat due to unilateral intranigral injection of 1-methyl-4-phenylpyridine (MPP+). Lange KW J Toxicol Clin Exp; 1989; 9(1):21-5. PubMed ID: 2787400 [TBL] [Abstract][Full Text] [Related]
16. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway. Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542 [TBL] [Abstract][Full Text] [Related]
17. 2,9-Dimethyl-beta-carbolinium, a neurotoxin occurring in human brain, is a potent inducer of apoptosis as 1-methyl-4-phenylpyridinium. Pavlovic S; Schulze G; Wernicke C; Bonnet R; Gille G; Badiali L; Kaminska A; Lorenc-Koci E; Ossowska K; Rommelspacher H Neuroscience; 2006; 139(4):1525-37. PubMed ID: 16517085 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the capability of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and pyridine derivatives to evoke parkinsonism]. Lermontiva NN; Soliakov LS; Bachurin SO; Tkachenko SE; Serkova TP Biull Eksp Biol Med; 1989 Jun; 107(6):699-701. PubMed ID: 2790166 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata. Staal RG; Sonsalla PK J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000 [TBL] [Abstract][Full Text] [Related]
20. The halogenated tetrahydro-beta-carboline "TaClo": a progressively-acting neurotoxin. Heim C; Sontag KH J Neural Transm Suppl; 1997; 50():107-11. PubMed ID: 9120411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]